Grants and Contributions:
Title:
Covid-19 - SARS-CoV-2 Antigen Point of Care Test
Agreement Number:
959276
Agreement Value:
$206,496.00
Agreement Date:
Nov 9, 2020 - Feb 28, 2021
Description:
To develop a LFIA based SARS-COV-2 Antigen Point-of-Care (POCT) Test to detect SARS-CoV-2 virus from nasopharyngeal swab samples, nasal swab samples or saliva samples collected from patients post symptom onset within the first 7days with sensitivity>95%, specificity>98%, designed for point of care use.
Organization:
National Research Council Canada
Expected Results:
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Location:
Burnaby, British Columbia, CA V5J 5H6
Reference Number:
172-2020-2021-Q3-959276
Agreement Type:
Contribution
Report Type:
Grants and Contributions
Recipient Business Number:
859367245
Recipient Type:
For-profit organization
Recipient's Operating Name:
Artron
Recipient's Legal Name:
Artron BioResearch Inc.
Federal Riding Name:
Burnaby South
Federal Riding Number:
59003
Program:
Industrial Research Assistance Program – Contributions to Firms
Program Purpose:
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Coverage:
IRAP Contributions to Firms projects stimulate wealth creation for Canada through technological innovation.
NAICS Code:
541710